BIG
CYTK icon

Brooklyn Investment Group’s Cytokinetics CYTK Stock Holding History

Brooklyn Investment Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697K Buy
10,581
+15
+0.1% +$953 0.02% 789
2025
Q4 		$652K Buy
+10,566
New +$657K 0.03% 513
2025
Q3 		– Sell
-1,498
Closed -$49.5K – 1169
2025
Q2 		$49.5K Buy
1,498
+1,398
+1,398% +$48.6K 0.01% 1341
2025
Q1 		$4.02K Buy
100
+56
+127% +$2.57K ﹤0.01% 1899
2024
Q4 		$2.07K Buy
+44
New +$2.29K ﹤0.01% 1452

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brooklyn Investment Group's CYTK Position: Q1 2026 in Review

Brooklyn Investment Group increased its Cytokinetics (CYTK) stake by 0.14% in Q1 2026, buying an estimated $953 and bringing the position to 10,581 shares worth $697K. The position accounts for 0.02% of the portfolio, ranked #789.

Brooklyn Investment Group first reported a position in CYTK in Q4 2024 and has held it in 5 quarters since. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Brooklyn Investment Group held 10,581 shares of Cytokinetics worth $697K as of Q1 2026.
  • Brooklyn Investment Group bought 15 Cytokinetics shares in Q1 2026, an estimated $953.
  • Cytokinetics made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #789 holding.
  • Brooklyn Investment Group first reported a position in Cytokinetics in Q4 2024 and has held it in 5 quarters since.
  • 440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.